CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. NYSE · United States

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) news

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is a public biotech or pharmaceutical company listed on NYSE under the ticker CRL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CHARLES RIVER LABORATORIES INTERNATIONAL, INC. news

We have not published a story on CHARLES RIVER LABORATORIES INTERNATIONAL, INC. yet. When there is news, it will appear here.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual financials

Line	FY ended Dec 27, 2025	FY ended Dec 28, 2024
Net income (loss)	-$144.3 million	$22.2 million
Cash from operations	$737.6 million	$734.6 million
Cash and equivalents	$213.8 million	$194.6 million

Latest balance sheet, Jun 27, 2026 (10-Q): cash and equivalents $192.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

What is the ticker symbol of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. trades under the ticker CRL on NYSE.

Where is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. listed?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is listed on NYSE.

Which country or territory is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. listed under?

Our directory records CHARLES RIVER LABORATORIES INTERNATIONAL, INC. under United States.

Does aibio.space cover CHARLES RIVER LABORATORIES INTERNATIONAL, INC.?

aibio.space lists CHARLES RIVER LABORATORIES INTERNATIONAL, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

Is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. profitable?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported a net loss of $144.3 million for the fiscal year ended Dec 27, 2025, and generated $737.6 million of cash from operations, per its annual report to the SEC.

How much cash does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. have?

$192.0 million in cash at Jun 27, 2026, per its 10-Q.

Investor discussion: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Members talk about CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:CRL on TradingView.

Listing details

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Ticker: CRL
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction